P250. Experience and training in dye spray colonoscopy amongst gastroenterology trainees in southwest United Kingdom
A. Terlevich1, P. Marden1
1North Bristol NHS trust, Gastroenterology, Bristol, United Kingdom
Background: The British Society of Gastroenterology (BSG) guidelines for colorectal cancer (CRC) screening and surveillance in moderate and high risk groups, recommend pancolonic dye spraying (PDS) colonoscopy as the method of choice when screening for colorectal cancer and dysplasia in patients with Inflammatory bowel disease (IBD) . This study examines the experience and training opportunities in PDS colonoscopy for gastroenterology trainees in our region.
Methods: The southwest region of the United Kingdom has a population of 4.5 million people served by 12 NHS trusts.
All Gastroenterology trainees were surveyed by anonymous questionnaire.
Of the 24 trainees questioned, 20 responded (83%). 85% of trainees were performing colonoscopy with an average of 140 colonoscopies performed amongst theses trainees. 25% of trainees were in their last 2 years of training with a mean of 370 colonoscopies performed each.
Results: 25% of trainees had never seen a PDS colonoscopy with an average of 4.9 PDS colonoscopies seen per trainee.
59% of those performing colonoscopy had never performed PDS colonoscopy. Those trainees that had performed a PDS colonscopy had performed an average of 3.9 PDS colonoscopies.
Out of the trainees in their last 2 years of training, 50% had performed no PDS colonoscopies, 1 had performed 1 and 1 trainee had performed 4, with an average amongst the most experienced trainees of 1.25 PDS colonoscopies performed.
No trainees had received specific training in PDS colonoscopy outside of their usual training list.
Conclusions: Previous evidence has shown a poor uptake of routine use of PDS colonoscopy for surveillance in IBD in our area . Our survey of Gastroenterology trainees has shown a lack of experience and training in PDS colonoscopy.
1. Cairns SR, Scholefield JH, Steele RJ et al. (2010), Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut, 666690.
2. B Hudson, JT Green, M Lockett (2011), Updated BSG guidelines for cancer surveillance in IBD improving consensus and changing practice? Gut, A203-A204.